About this episode
Earlier this month, President Donald Trump announced the U.S. would impose up to a 200% tariff on imported pharmaceuticals, though he would give them up to a year and a half before fully implementing the tariffs. Trump’s goal is to bring more manufacturing to the United States, but one pharmaceutical CEO, Richard Saynor of Sandoz, says there is little incentive to build in the U.S. Jessica Mendoza hosts.
Further Listening:- Why Trump Pushed His Tariff Deadline
- Inside the Surprise U.S.-China Trade Deal
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Get every episode summarized
Each time The Journal. publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Journal.
The MAHA Shake-Up at Steak ‘n Shake
The Journal.
Sep 11, 202619:58completed
What Happened to the Affordable Car?
The Journal.
Sep 10, 202619:09completed
A Data Center Offered $26 Million for Her Land. She Said No.
The Journal.
Sep 9, 202629:22completed
AI Companies Are Buying and Destroying Used Books
The Journal.
Sep 8, 202620:43completed